Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by 1hot-techwomanon Jan 17, 2025 3:41pm
96 Views
Post# 36409546

RE:RE:RE:RE:RE:Stock price

RE:RE:RE:RE:RE:Stock price
BrokerG wrote: Organigram is NOT profitable - Net income for the quarter ended Sept 30th was negative - 5M and for the year it was negative -45M.
Auxly was NOT profitable for the year ended 2023-12-31 however did show a small profit the last tow quarters. I will give you that one.

I mentioned HITI in my previous post. Their year end was NOT profitable but the last quarter was. 

In other words the majority of Cannabis companies are not profitable with a few showing a first time quarterly profit.

The point is WHY is Canopy getting hammered while the Majority of other similar companies are up nicely today. Curaleaf and Verano are up 10% and 7.5% respectively. 
All I can say is I hope Canopy is not looking at making another ridiculous acquisition

Organigram Reports Fourth Quarter and Fiscal 2024 Results
 -- Fiscal 2024 net revenue of $159.8 million -- 17.6% year-over-year growth in Organigram's recreational shipped sales in Fiscal 2024 -- Q4 Fiscal 2024 adjusted gross margin1 of 37% -- Q4 Fiscal 2024 adjusted EBITDA2 of $5.9 million or 13% of net revenue -- Q4 Fiscal 2024 cash flow from operations of $8.9 million -- Became Canada's largest cannabis company by market share following the acquisition of Motif Labs subsequent to year end 

<< Previous
Bullboard Posts
Next >>